Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model

Nanoparticles, to be used in biomedical applications, have been the subject of extensive investigation in recent years. Recently, zirconia and iron have gained significant relevance to the field due to their superior mechanical and structural qualities as well as their numerous biological applicatio...

Full description

Bibliographic Details
Main Authors: Ifra SanaUllah, Saira Riaz, Irfan Ullah Khan, Daoud Ali, S. Shamaila, M. Akram Raza, Amna Sajjad, Anjum N. Sabri, Shahzad Naseem
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Arabian Journal of Chemistry
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1878535223007293
_version_ 1797615950901542912
author Ifra SanaUllah
Saira Riaz
Irfan Ullah Khan
Daoud Ali
S. Shamaila
M. Akram Raza
Amna Sajjad
Anjum N. Sabri
Shahzad Naseem
author_facet Ifra SanaUllah
Saira Riaz
Irfan Ullah Khan
Daoud Ali
S. Shamaila
M. Akram Raza
Amna Sajjad
Anjum N. Sabri
Shahzad Naseem
author_sort Ifra SanaUllah
collection DOAJ
description Nanoparticles, to be used in biomedical applications, have been the subject of extensive investigation in recent years. Recently, zirconia and iron have gained significant relevance to the field due to their superior mechanical and structural qualities as well as their numerous biological applications. In this research, Fe3O4-stabilized zirconia nanopowders are fabricated using a low-cost sol–gel approach. Iron oxide sol is added in 1–10 wt% increments to a 0.1 M zirconia sol. The obtained crystallite size values match well with previously reported values for the tetragonally stable (t-zirconia) phase. Hardness values of approximately 1278 HV, along with fracture toughness values of ∼ 24.48 MPa.m-1/2 are observed for stable tetragonal zirconia. Results from cell lysis experiments indicate that the synthesized nanoparticles have the potential to combat cancerous cells. An encapsulation efficacy of up to ∼ 73% is observed after a 120-minute time period. Radio labeling techniques are employed to label the as-synthesized zirconia nanoparticles using Sodium Pertechnetate (Na99mTcO4) labeled radiopharmaceuticals, allowing for biodistribution assessment. Multiple CT scans of rabbits are performed to obtain accurate results and evaluate their survival. Studies show that radiolabeled nanoparticles are highly absorbed in the animals' bladders, making them a promising choice for tumor therapy. Various physical properties of the animals are periodically examined after administration of the nanoparticle-based injection for several months, and no abnormalities are found. The results obtained through these characterizations indicate that these nanoparticles can be used as future therapeutic agents as well as drug carriers.
first_indexed 2024-03-11T07:34:15Z
format Article
id doaj.art-cb28785e53804d4bbd4bf41e1d3e180a
institution Directory Open Access Journal
issn 1878-5352
language English
last_indexed 2024-03-11T07:34:15Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Arabian Journal of Chemistry
spelling doaj.art-cb28785e53804d4bbd4bf41e1d3e180a2023-11-17T05:25:49ZengElsevierArabian Journal of Chemistry1878-53522023-12-011612105267Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal modelIfra SanaUllah0Saira Riaz1Irfan Ullah Khan2Daoud Ali3S. Shamaila4M. Akram Raza5Amna Sajjad6Anjum N. Sabri7Shahzad Naseem8Centre of Excellence in Solid State Physics, University of the Punjab, QAC, Lahore 54590, PakistanCentre of Excellence in Solid State Physics, University of the Punjab, QAC, Lahore 54590, Pakistan; Corresponding authors.Department of Cyclotron and Allied Radiopharmaceutics, INMOL Cancer Hospital, Lahore 54600, PakistanDepartment of Zoology, College of Science, King Saud University, Riyadh 11451, Saudia ArabiaWaterloo Institute for Nanotechnology, University of Waterloo, Ontario, CanadaCentre of Excellence in Solid State Physics, University of the Punjab, QAC, Lahore 54590, PakistanDepartment of Zoology, Government College University, Faisalabad, PakistanDepartment of Microbiology and Molecular Genetics, University of the Punjab, QAC, Lahore 54590, PakistanCentre of Excellence in Solid State Physics, University of the Punjab, QAC, Lahore 54590, Pakistan; Corresponding authors.Nanoparticles, to be used in biomedical applications, have been the subject of extensive investigation in recent years. Recently, zirconia and iron have gained significant relevance to the field due to their superior mechanical and structural qualities as well as their numerous biological applications. In this research, Fe3O4-stabilized zirconia nanopowders are fabricated using a low-cost sol–gel approach. Iron oxide sol is added in 1–10 wt% increments to a 0.1 M zirconia sol. The obtained crystallite size values match well with previously reported values for the tetragonally stable (t-zirconia) phase. Hardness values of approximately 1278 HV, along with fracture toughness values of ∼ 24.48 MPa.m-1/2 are observed for stable tetragonal zirconia. Results from cell lysis experiments indicate that the synthesized nanoparticles have the potential to combat cancerous cells. An encapsulation efficacy of up to ∼ 73% is observed after a 120-minute time period. Radio labeling techniques are employed to label the as-synthesized zirconia nanoparticles using Sodium Pertechnetate (Na99mTcO4) labeled radiopharmaceuticals, allowing for biodistribution assessment. Multiple CT scans of rabbits are performed to obtain accurate results and evaluate their survival. Studies show that radiolabeled nanoparticles are highly absorbed in the animals' bladders, making them a promising choice for tumor therapy. Various physical properties of the animals are periodically examined after administration of the nanoparticle-based injection for several months, and no abnormalities are found. The results obtained through these characterizations indicate that these nanoparticles can be used as future therapeutic agents as well as drug carriers.http://www.sciencedirect.com/science/article/pii/S1878535223007293Iron oxideZirconiaHoneyAnticancerDrug loading
spellingShingle Ifra SanaUllah
Saira Riaz
Irfan Ullah Khan
Daoud Ali
S. Shamaila
M. Akram Raza
Amna Sajjad
Anjum N. Sabri
Shahzad Naseem
Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
Arabian Journal of Chemistry
Iron oxide
Zirconia
Honey
Anticancer
Drug loading
title Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
title_full Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
title_fullStr Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
title_full_unstemmed Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
title_short Cell Lysis, labeling efficacy and biodistribution of intravenously administered Technetium-99 m labeled multifunctional zirconia nanoparticles in animal model
title_sort cell lysis labeling efficacy and biodistribution of intravenously administered technetium 99 m labeled multifunctional zirconia nanoparticles in animal model
topic Iron oxide
Zirconia
Honey
Anticancer
Drug loading
url http://www.sciencedirect.com/science/article/pii/S1878535223007293
work_keys_str_mv AT ifrasanaullah celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT sairariaz celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT irfanullahkhan celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT daoudali celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT sshamaila celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT makramraza celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT amnasajjad celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT anjumnsabri celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel
AT shahzadnaseem celllysislabelingefficacyandbiodistributionofintravenouslyadministeredtechnetium99mlabeledmultifunctionalzirconiananoparticlesinanimalmodel